Literature DB >> 28325212

Chemokine Receptor Signaling and the Hallmarks of Cancer.

R A Lacalle1, R Blanco1, L Carmona-Rodríguez1, A Martín-Leal1, E Mira1, S Mañes2.   

Abstract

The chemokines are a family of chemotactic cytokines that mediate their activity by acting on seven-transmembrane-spanning G protein-coupled receptors. Both the ability of the chemokines and their receptors to form homo- and heterodimers and the promiscuity of the chemokine-chemokine receptor interaction endow this protein family with enormous signaling plasticity and complexity that are not fully understood at present. Chemokines were initially identified as essential regulators of homeostatic and inflammatory trafficking of innate and adaptive leucocytes from lymphoid organs to tissues. Chemokines also mediate the host response to cancer. Nevertheless, chemokine function in this response is not limited to regulating leucocyte infiltration into the tumor microenvironment. It is now known that chemokines and their receptors influence most-if not all-hallmark processes of cancer; they act on both neoplastic and untransformed cells in the tumor microenvironment, including fibroblasts, endothelial cells (blood and lymphatic), bone marrow-derived stem cells, and, obviously, infiltrating leucocytes. This review begins with an overview of chemokine and chemokine receptor structure, to better define how chemokines affect the proliferation, survival, stemness, and metastatic potential of neoplastic cells. We also examine the main mechanisms by which chemokines regulate tumor angiogenesis and immune cell infiltration, emphasizing the pro- and antitumorigenic activity of this protein superfamily in these interrelated processes.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Antitumor immune response; Apoptosis; Cancer stem cells; Chemokines; Proliferation; Receptor; Senescence

Mesh:

Substances:

Year:  2016        PMID: 28325212     DOI: 10.1016/bs.ircmb.2016.09.011

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  35 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

2.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Trial watch: DNA-based vaccines for oncological indications.

Authors:  Stefano Pierini; Renzo Perales-Linares; Mireia Uribe-Herranz; Jonathan G Pol; Laurence Zitvogel; Guido Kroemer; Andrea Facciabene; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

4.  CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.

Authors:  Min Yao; Wei Fang; Curtis Smart; Qingting Hu; Shixia Huang; Nehemiah Alvarez; Patrick Fields; Nikki Cheng
Journal:  Mol Cancer Res       Date:  2018-11-16       Impact factor: 5.852

Review 5.  Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.

Authors:  Elena García-Martínez; Melody Smith; Aitziber Buqué; Fernando Aranda; Francisco Ayala de la Peña; Alejandra Ivars; Manuel Sanchez Cánovas; Ma Angeles Vicente Conesa; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

6.  Development of a novel chemokine signaling-based multigene signature to predict prognosis and therapeutic response in colorectal cancer.

Authors:  Xin Qi; Donghui Yan; Jiachen Zuo; Rui Wang; Jiajia Chen
Journal:  J Zhejiang Univ Sci B       Date:  2021-12-15       Impact factor: 3.066

7.  CXCL13 Signaling in the Tumor Microenvironment.

Authors:  Muzammal Hussain; Jinsong Liu; Gui-Zhen Wang; Guang-Biao Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Endocytosis is required for CXC chemokine receptor type 4 (CXCR4)-mediated Akt activation and antiapoptotic signaling.

Authors:  Elizabeth J English; Sarah A Mahn; Adriano Marchese
Journal:  J Biol Chem       Date:  2018-06-13       Impact factor: 5.157

9.  Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.

Authors:  Marie K Malone; Karly Smrekar; Sunju Park; Brianna Blakely; Alec Walter; Nicholas Nasta; Jay Park; Michael Considine; Ludmila V Danilova; Niranjan B Pandey; Elana J Fertig; Aleksander S Popel; Kideok Jin
Journal:  Cancer Biol Ther       Date:  2020-03-26       Impact factor: 4.742

Review 10.  At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.

Authors:  Gary D Luker; Jinming Yang; Ann Richmond; Stefania Scala; Claudio Festuccia; Margret Schottelius; Hans-Jürgen Wester; Johann Zimmermann
Journal:  J Leukoc Biol       Date:  2020-10-26       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.